Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02658708 · ClinicalTrials.gov registry record · Phase 1
Bright Light on Fatigue in Women Being Treated for Breast Cancer
A Phase 1 study of Breast Cancer and Breast Neoplasms, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- Phase 1
- Development phase
- 19
- Enrollment target
- 1
- Study location
NCT02658708: Completed Phase 1 study of Breast Cancer and Breast Neoplasms, sponsored by Washington University School of Medicine.
NCT02658708 is a Phase 1 study of Breast Cancer and Breast Neoplasms that has completed, run by Washington University School of Medicine. The registered enrollment target is 19 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02658708, a Phase 1 study of Breast Cancer and Breast Neoplasms, has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 19 participants
- Enrollment target
- 1
- Study location
Study Summary
This proposed study will examine feasibility and implement therapeutic bright light that is tailored to the individual's circadian typology to estimate its therapeutic effects on sleep/wake patterns and fatigue in breast cancer patients undergoing chemotherapy.
Primary Outcome
-Feasibility of the procedures will be assessed by descriptive analysis
Conditions Studied
Interventions
- OTHER Bright blue-green light using light visor cap
- OTHER Dim red light using light visor cap
- OTHER European Organization for Research and Treatment of Cancer-Quality of Life Questionnaire
- OTHER Epworth Sleepiness Scale
- OTHER Pittsburgh Sleep Quality Index
Study Locations (1)
Missouri
- Washington University School of Medicine - St Louis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2015-10-12 |
| Est. Completion | 2017-05-09 |
| Phase | Phase 1 |
What the finished NCT02658708 record still lists
NCT02658708 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 19 participants, a relatively small participant target, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (99% lower).
The record links to 4 conditions, with Breast Cancer appearing as the primary indexed condition, and to 5 interventions - of which Bright blue-green light using light visor cap is the first listed.
NCT02658708 reports a single indexed study location in Missouri.
Frequently Asked Questions
What is clinical trial NCT02658708 about?
NCT02658708 is a clinical study titled "Bright Light on Fatigue in Women Being Treated for Breast Cancer". This proposed study will examine feasibility and implement therapeutic bright light that is tailored to the individual's circadian typology to estimate its therapeutic effects on sleep/wake patterns and fatigue in breast cancer patients undergoing chemotherapy.
What is the current status of trial NCT02658708?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 19 participants. The study started on 2015-10-12. Estimated completion is 2017-05-09.
What conditions does trial NCT02658708 study?
This clinical trial studies the following conditions: Breast Cancer, Breast Neoplasms, Cancer of the Breast, Cancer of Breast.
What interventions are being tested in trial NCT02658708?
The interventions under investigation include: Bright blue-green light using light visor cap (OTHER), Dim red light using light visor cap (OTHER), European Organization for Research and Treatment of Cancer-Quality of Life Questionnaire (OTHER), Epworth Sleepiness Scale (OTHER), Pittsburgh Sleep Quality Index (OTHER).
Who is sponsoring clinical trial NCT02658708?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02658708 being conducted?
This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02658708's enrollment target sits among peer trials
19 1114th of 1224 higher than 108 of 1,224 other Breast Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Breast Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
VS-6766+Abema+Fulv in Met HR+/HER- BC
RECRUITING · Phase 1
-
KK-LC-1 TCR-T Cell Therapy for Gastric, Breast, Cervical, and Lung Cancer
RECRUITING · Phase 1
-
Focused Ultrasound and Gemcitabine in Breast Cancer
RECRUITING · Phase 1
-
A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies
RECRUITING · Phase 1
-
Study of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid Tumors
RECRUITING · Phase 1
-
A Study of MT-4561 in Patients With Various Advanced Solid Tumors
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03207464 · 19 participants · Phase 1
Molecular Imaging of NET Using [C-11]MRB-PET in MS
- NCT04318717 · 19 participants · Phase 2
Pembrolizumab and Hypofractionated Radiation Therapy for the Treatment of Mucosal Melanoma
- NCT05103904 · 19 participants · Phase 2
Lenvatinib for the Treatment of Recurrent Hepatocellular Carcinoma After Liver Transplant
- NCT05607407 · 19 participants · Phase 2
Methimazole in Patients With Progressive Glioblastoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI